tbuckley/cabot-search huggingface dataset:
Effect of meditation on mental stress and job satisfaction of teachers of Banaras Hindu University
Authors: Pooja Mishra, Moradhvaj Singh, Santosh Yaduvanshi, D K Dureha
Journal: British Journal of Sports Medicine (2010)

Introduction Studies show that stress plays an important role on teacher's health and their job satisfaction. Usually the people are not aware about the amount of their stress that is, inadequate. They are not aware as how to reduce their stress. At work, they have to meet the expectation of others and put their emotions on hold. Another key component is job satisfaction which they want to enhance. To achieve job satisfaction, they have to cope up with both internal as well as external pressure. Background The purpose of the study was to find the effect of meditation on mental stress and job satisfaction of teachers of Banaras Hindu University. Thirty teachers (n=30) were randomly selected for the study. In this study two separate questionnaires were used for assessing the mental stress and job satisfaction. Method The t test was applied to find out the effect of effect of 12 week training of meditation on mental stress and job satisfaction of teachers of Banaras Hindu University. For testing the difference between mean gain of initial test and final test the level of significance was set at 0.05 level of significance. Result On the basis of findings, it can be concluded from the study that the meditation practice among teachers was significantly improved from the 12 week training of meditation on mental stress and job satisfaction of teachers of Banaras Hindu University.
Poor prognosis of patients retransplanted for recurrent liver disease due to hepatitis C virus C F�ray, A Habsanne, D Samuel, O Farges, M Reynes*, H Bismuth, Hepato-Biliary Surgery and Liver Transplant Center, Dpt Pathology*, Paul Brousse Hospital. Villejuif 94800, FRANCE
Journal: Hepatology (1995)

Cow calves were infected with Japanese encephalitis virus (JEV) by parenteral inoculation. One batch was reinfected with JEV, followed by West Nile virus (WNV), while another batch was reinfected directly with WNV. No viraemia due to either JEV or WNV was demonstrated in any of the calves. Culex tritaeniorhynchus mosquitoes fed on 4 of the calves infected with JEV during the first 10 d had no detectable virus, nor did they transmit the virus by bite to susceptible baby chickens. In another experiment, calves did not develop viraemia after infected C. tritaeniorhynchus mosquitoes were allowed to feed on them. Neutralizing and/or haemagglutination-inhibiting antibodies against JEV were demonstrated in 6 of the 11 calves, which explains the high proportion of JE seropositives among cattle in India. All the 5 calves that were infected with WNV subsequent to JEV developed neutralizing and haemagglutination-inhibiting antibodies against WNV also. The study indicates that cattle do not play a role in the maintenance of JEV in nature.
Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome
Authors: K. E. Vitting
Journal: JAMA (1990)

The frequency and pathophysiology of hyponatremia were studied in the acquired immunodeficiency syndrome. Of 71 hospitalized patients surveyed retrospectively, hyponatremia was observed in 37 (52%). Of 48 patients studied prospectively, 27 (56%) were hyponatremic. In 16 hyponatremic patients, volume status; serum and urine osmolalities; renal, adrenal, and thyroid function; and plasma vasopressin levels were assessed. Urine osmolalities were inappropriately elevated (mean, 377 mmol/kg of water) relative to serum osmolalities (mean, 268 mmol/kg of water). Four patients had moderate renal insufficiency. Plasma vasopressin levels were elevated in 15 patients, with the highest levels seen in patients who died (median, 7.08 pmol/L). Hyponatremia of multiple etiologies occurred in a majority of inpatients with the acquired immunodeficiency syndrome, often following the administration of hypotonic fluids, and was associated with a 30% (8/27) short-term mortality. (<i>JAMA</i>. 1990;263:973-978)
Doxycycline Reduces Fibril Formation in a Transgenic Mouse Model of AL Amyloidosis
Authors: David C Seldin, Jennifer Ward, Ruiyi Ren, Gianluca Toraldo, Pamela T SooHoo, Jian Guan, Carl O'Hara, Ravi Jasuja, Vickery Trinkaus-Randall, Ronglih Liao, Lawreen H Connors
Journal: Blood (2011)
EARLY DIAGNOSIS OF CHOLELITHIASIS.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diving Reflex Slows Heart Rate; May Be Key to Unexplained Deaths
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery
Journal: BMJ (1999)

Objectives To determine whether preoperative optimisation of oxygen delivery improves outcome after major elective surgery, and to determine whether the inotropes, adrenaline and dopexamine, used to enhance oxygen delivery influence outcome.Design Randomised controlled trial with double blinding between inotrope groups.Setting York District Hospital, England.Subjects 138 patients undergoing major elective surgery who were at risk of developing postoperative complications either because of the surgery or the presence of coexistent medical conditions.Interventions Patients were randomised into three groups.Two groups received invasive haemodynamic monitoring, fluid, and either adrenaline or dopexamine to increase oxygen delivery.Inotropic support was continued during surgery and for at least 12 hours afterwards.The third group (control) received routine perioperative care.Main outcome measures Hospital mortality and morbidity.Results Overall, 3/92 (3%) preoptimised patients died compared with 8/46 controls (17%) (P = 0.007).There were no differences in mortality between the treatment groups, but 14/46 (30%) patients in the dopexamine group developed complications compared with 24/46 (52%) patients in the adrenaline group (difference 22%, 95% confidence interval 2% to 41%) and 28 patients (61%) in the control group (31%, 11% to 50%).The use of dopexamine was associated with a decreased length of stay in hospital.Conclusion Routine preoperative optimisation of patients undergoing major elective surgery would be a significant and cost effective improvement in perioperative care.
THE CONSERVATION OF THE OVARIES.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Degree and Data
Authors: Samuel Wilkinson, Deepak Cyril, D Souza
Journal: JAMA (2014)

Mark S. Sulkowski, MD; Susanna Naggie, MD; Jacob Lalezari, MD; Walford Jeffrey Fessel, MD; Karam Mounzer, MD; Margaret Shuhart, MD; Anne F. Luetkemeyer, MD; David Asmuth, MD; Anuj Gaggar, MD, PhD; Liyun Ni, MS; Evguenia Svarovskaia, PhD; Diana M. Brainard, MD; William T. Symonds, PharmD; G. Mani Subramanian, MD, PhD; John G. McHutchison, MD; Maribel Rodriguez-Torres, MD; Douglas Dieterich, MD; for the PHOTON-1 Investigators
Hang Gliding
Authors: E. Shannon Stauffer
Journal: JAMA (1975)

<h3>To the Editor.—</h3> I was particularly happy to see attention called to the injuries associated with hang gliding. Drs Krissoff and Eiseman correctly point out the dangers of this new sport; however, our recent experience would take exception to his conclusion that the novice hang glider is seldom injured. I know of five young novice hang gliders who suffered permanent quadriplegia or paraplegia from their accidents. Admittedly, hang gliding is a dangerous sport. Those who are experienced enough to fly high and far may be taking a greater risk at fatal injuries. However, one cannot ignore the excitement and challenge that this sport offers the teenager. It is just unconscionable to allow them to fly any machine without the basic rudiments of aerodynamics and safety precautions. I am as loathe as the next person to infringe upon the rights and liberties of others. But, it is not ethically or morally
From the Centers for Disease Control. Year 2000 national health objectives
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium.
Authors: H S Taylor, A Arici, D Olive, P Igarashi
Journal: Journal of Clinical Investigation (1998)

Hox genes are well-known transcriptional regulators that play an essential role in directing embryonic development. Mice that are homozygous for a targeted disruption of the Hoxa10 gene exhibit uterine factor infertility. We have recently demonstrated that HOXA10 is expressed in the adult human uterus. To examine expression of HOXA10 during the menstrual cycle, Northern blot analysis and in situ hybridization were performed. Expression of HOXA10 dramatically increased during the midsecretory phase of the menstrual cycle, corresponding to the time of implantation and increase in circulating progesterone. Expression of HOXA10 in cultured endometrial cells was stimulated by estrogen or progesterone. Stimulation of HOXA10 by progesterone was concentration-dependent within the physiologic range, and the effect of estrogen was inhibited by cycloheximide. These results identify sex steroids as novel regulators of HOX gene expression. HOXA10 may have an important function in regulating endometrial development during the menstrual cycle and in establishing conditions necessary for implantation in the human.
Evaluation of epidermal growth factor receptor (EGFR) as a prognostic factor for survival in non-small-cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy as first-line treatment
Authors: M. Janas, L. R. Bailey, K. Schmidt, N. Bindslev, M. Wolf, A. Fandi, J. Askaa, R. Herbst, G. Giaccone, D. H. Johnson
Journal: Journal of Clinical Oncology (2004)

7024 Background: Two double-blind placebo-controlled randomized multicenter trials (INTACT 1 & 2) in NSCLC failed to show survival benefit for gefitinib ('Iressa', ZD1839) in combination with first-line platinum-based chemotherapy. However, these large studies provide an opportunity to evaluate if EGFR staining is prognostic for survival. Methods: Tumor biopsies (n=516) taken between diagnosis and start of therapy were assessed by immunohistochemistry for EGFR using the DakoCytomation EGFR pharmDx assay™. The analysis was stratified by trial and performed independently for patients randomized to placebo and gefitinib. A restricted backwards elimination Cox regression analysis was conducted to identify independent EGFR factors that were statistically significant (p<0.10) and these were also tested for treatment interaction to assess if they served as predictive factors. Results: The analysis found 2 statistically significant EGFR-based prognostic factors representing the growth pattern and percent membrane staining in patients treated with gefitinib (p=0.0023, df=2) and placebo (p=0.0128, df=2). A further analysis including interaction terms of the EGFR variables with treatment confirmed these as highly significant (p<0.0001, df=2) but not the interaction. The EGFR factors remained independently prognostic when conditioning for previously found factors (PS2; stage IV; bone, brain, liver metastasis; sex; histology; weight loss) and were comparably significant (p=0.0011 and p=0.0158). Results will also be presented for secondary endpoints (time to progression, objective response). Conclusion: While the majority of previous studies indicate higher EGFR expression correlates with poor survival, the analysis from 2 large Phase III trials provides statistically significant evidence that the combination of EGFR expression and growth pattern is a strong prognostic indicator for improved survival within this setting. 'Iressa' is a trademark of the AstraZeneca group of companies 'PharmDx assay' is a trademark of DakoCytomation Author Disclosure Employment or Leadership Consultant or Advisory Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration AstraZeneca Pharmaceuticals; DakoCytomation DakoCytomation; Genentech AstraZeneca AstraZeneca
Undersøgelser over de serologiske Blodtype-Egenskaber M og N (Landsteiner &amp;amp; Levine)
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Polychlorinated Biphenyls and Methylmercury Act Synergistically to Reduce Rat Brain Dopamine Content in Vitro
Authors: Jeffrey C. Bemis, Richard F. Seegal
Journal: Environmental Health Perspectives (1999)

Consumption of contaminated Great Lakes fish by pregnant women is associated with decreased birth weight and deficits in cognitive function in their infants and children. These fish contain many known and suspected anthropogenic neurotoxicants, making it difficult to determine which contaminant(s) are responsible for the observed deficits. We have undertaken a series of experiments to determine the relevant toxicants by comparing the neurotoxic effects of two of these contaminants--polychlorinated biphenyls (PCBs) and methylmercury (MeHg)--both of which are recognized neurotoxicants. Striatal punches obtained from adult rat brain were exposed to PCBs only, MeHg only, or the two in combination, and tissue and media concentrations of dopamine (DA) and its metabolites were determined by high performance liquid chromatography. Exposure to PCBs only reduced tissue DA and elevated media DA in a dose-dependent fashion. Exposure to MeHg only did not significantly affect either measure. However, when striatal punches were simultaneously exposed to PCBs and MeHg, there were significantly greater decreases in tissue DA concentrations and elevations in media DA than those caused by PCBs only, in the absence of changes in media lactate dehydrogenase concentrations. Elevations in both tissue and media 3, 4-dihydroxyphenylacetic acid concentrations were also observed. We suggest that the significant interactions between these two toxicants may be due to a common site of action (i.e., toxicant-induced increases in intracellular calcium and changes in second messenger systems) that influences DA function. The synergism between these contaminants suggests that future revisions of fish-consumption guidelines should consider contaminant interactions.
Errata in Letters
Journal: JAMA (1973)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Nifedipine for Hypertensive Emergencies
Authors: R. L. Bloomfield
Journal: JAMA (1997)

<h3>To the Editor.</h3> —The article by Dr Grossman and colleagues<sup>1</sup>regarding recommendations for sublingual nifedipine uses the term "pseudoemergency." Unfortunately, this term is not common in the hypertensive literature, and its use suggests that there are primarily 2 clinical situations: true and false hypertensive emergencies. On the other hand, the term "urgency" suggests that the clinician has thoughtfully assessed the patient's condition and feels that the blood pressure elevation should be classified in a less-than-emergency category. Moreover, the authors should consider some useful alternatives, such as oral captopril, which are noted in textbooks on hypertension.<sup>2,3</sup>Another alternative is to use a lower dose of short-acting nifedipine, especially in elderly patients.<sup>4</sup> Some of the potential adverse effects of an otherwise effective therapy may be avoidable by a knowledge of the dose-response relationship. This may be true with diuretics, β-blockers, angiotensin-converting enzyme inhibitors, aspirin, digoxin, and calcium channel blockers, as well as
Parallel 19: Pediatric and Metabolic Liver Diseases: Clinical
Authors: Vicky Ng, Lisa Sorensen, Estella Alonso, Emily Fredericks, Wen Ye, Saul Karpen, Benjamin Shneider, Jorge Bezerra, Jean Molleston, Karen Murray, Philip Rosenthal, Kasper Wang, Kathleen Loomes, Paula Hertel, Nanda Kerkar, Kathleen Schwarz, Yumirle Turmelle, Barbara Haber, Averell Sherker, John Magee, Ronald Sokol
Journal: Hepatology (2015)
Dr Dad
Authors: Robert C. Morrow
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal